<p>Section I-- Identification and Measurement of Constitutive Activity</p> <ol> <p> <li>Constitutive activity at the cannabinoid CB<sub>1</sub> receptor and behavioral responses </li> <p>Katherine E. Hanlon and Todd W. Vanderah</p> <p> <li>Detecting constitutive activity and protean agonism at the cannabinoid-2 receptor. </li> <p>Massimiliano Beltramo, Rossella Brusa, Isabella Mancini, Paola Scandroglio, Massimiliano. Beltramo</p> <p> <li>Modulation of constitutive activity of the ghrelin receptor by use of pharmacological tools as well as mutagenesis </li> <p>Birgitte Holst and Jacek Mokrosiński </p> <p> <li>Assessment of constitutive activity and internalization of GPR54 (Kiss1-r). </li> <p>Macarena Pampillo and Andy Videsh Babwah</p> <p> <li>Assessment of Constitutive Activity in EP Prostanoid Receptors </li> <p>Hiromichi Fujino, Toshihiko Murayama, and John W. Regan</p> <p> <li>α<sub>1D</sub>-Adrenergic receptors: constitutive activity and reduced expression at the plasma membrane</li> <p>J Adolfo Garcia-Sáinz, M. Teresa Romero-Ávila and Luz del Carmen Medina</p> <p> <li>Constitutive activity of the histamine H<sub>1</sub> receptor</li> <p>Saskia Nijmeijer, Rob Leurs and Henry F Vischer</p> <p> <li>Constitutive activity of somatostatin receptor subtypes</li> <p>Anat Ben-Shlomo, Kolja Wawrowsky and Shlomo Melmed</p> <p> <li>Assessment of homologous internalization of constitutively active N111G mutant of AT<sub>1</sub> receptor</li> <p>Mohiuddin Ahmed Bhuiyan and Takafumi Nagatomo</p> <p> <li>Methods to detect cell surface expression and constitutive activity of GPR6</li> <p>Balakrishna M. Prasad, Bettye Hollins and Nevin A. Lambert</p> <p> <li>β<sub>3</sub>-adrenoceptor agonists and (antagonists as) inverse agonists: history, perspective, constitutive activity and stereospecific binding. </li> <p>Maria Grazia Perrone and Antonio Scilimati</p> <p> <li>Constitutive Activity of the Lutropin Receptor and its Allosteric Modulation by Receptor Heterodimerization</li> <p>Deborah L. Segaloff</p> <p> <li>Assessing Constitutive Activity of Extracellular Calcium-Sensing Receptors in Vitro and in Bone</li> <p>Wenhan Chang, Melita Dvorak, and Dolores Shoback</p> <p> <li>Constitutive Activity of Neural Melanocortin Receptors. </li> <p>Ya-Xiong Tao, Hui Huang, Zhi-Qiang Wang, Fan Yang, Jessica N. Williams, and Gregory V. Nikiforovich</p> <p> <li>Measurement of Constitutive Activity of BMP Type I receptors </li> <p>Peter ten Dijke</p> <p> <li>Probing the CA among dopamine D1 and D5 receptors and their mutants</li> <p>Bianca Plouffe, Jean-Philippe D’Aoust, Vincent Laquerre, Binhui Liang and Mario Tiberi</p> <p> <li>Identification of Gain-of-Function Variants of the Human Prolactin Receptor</li> <p>Vincent Goffin, Roman L. Bogorad, and Philippe Touraine</p> <p> <li>Investigations of Activated ACVR1/ALK2, a Bone Morphogenetic Protein (BMP) Type I Receptor that Causes Fibrodysplasia Ossificans Progressiva </li> <p>Frederick. Kaplan, Petra Seemann, Julia Haupt, Meiqi Xu, Vitali Lounev, Mary Mullins, Eileen M. Shore</p> <p> <li>Identification and evaluation of constitutively active thyroid stimulating hormone receptor mutations</li> <p>Joaquin Lado-Abeal, Leah R. Quisenberry, and Isabel Castro-Piedras</p> <p> <li>Assessment of constitutive activity of a G protein-coupled receptor, Cpr2, in Cryptococcus neoformans by heterologous and homologous methods </li> <p>Chaoyang Xue, Yina Wang, and Yen-Ping Hsueh</p> <p> <li>In vitro and in vivo assessment of mu opioid receptor constitutive activity. </li> <p>Edward J. Bilsky, Denise Giuvelis, Melissa D. Osborn, Christina M. Dersch, Heng Xu and Richard B. Rothman</p> <p> <li>Constitutively active µ-opioid methods</li> <p>Mark. Connor and John Traynor</p> <p> <li>Protein Kinase Ck2 is a Constitutively-Active Enzyme That Promotes Cell Survival: Strategies To Identify Ck2 Substrates and Manipulate Its Activity In Mammalian Cells </li> <p>Jacob P. Turowec, James S. Duncan, Ashley C. French, Laszlo Gyenis, Nicole A. St. Denis, Greg J. Vilk, and David W. Litchfield </p> <p> <li>Assessment of Ck2 Constitutive Activity In Cancer Cells</li> <p>Maria Ruzzene, Giovanni Di Maira, Kendra Tosoni, and Lorenzo A. Pinna</p> <p> <li>Structural basis of the constitutive activity of protein kinase CK2</li> <p>Birgitte B. Olsen, Barbara Guerra, Karsten Niefind and Olar-Georg Issinger font error</p> <p> <li>Measuring the Constitutive Activation of c-Jun N-terminal Kinase Isoforms</li> <p>Ryan T. Nitta, Shawn S. Badal, and Albert J. Wong</p> <p> <li>Measurement of constitutive MAPK and PI3K/AKT signaling activity in human cancer cell lines.</li> <p>Keiran S.M. Smalley</p> <p> <li>Constitutive activity of GPR40/FFA1: Intrinsic or assay dependent?</li> <p>Leigh A Stoddart<sup> </sup>and Graeme Milligan</p> <p> <li>Constitutive activity of TRP channels: methods for measuring the activity and its outcome</li> <p>Baruch Minke</p> <p> <li>Measurement of Orexin (Hypocretin) and Substance P Effects On Constitutively Active Inward Rectifier K+ Channels in Brain Neurons</li> <p>Yasuko Nakajima and Shigehiro Nakajima</p> <p> <li>Characterization of G protein receptor kinase 4 and measuring its constitutive activity in vivo</li> <p>Bradley T. Andresen</p> <p> <li>Voltage-clamp based methods for the detection of constitutively active acetylcholine-gated I<sub>K,ACh </sub>channels in the diseased heart </li> <p>Niels Voigt, Samy Makary, Stanley Nattel, Dobromir Dobrev</p> <p> <li>Assaying Wave and WASH complex constitutive activities towards the Arp2/3 complex. </li> </ol> <p>Emmanuel DERIVERY and Alexis GAUTREAU </p>